|
Insider Trading: PAR PHARMACEUTICAL COMPANIES, INC.
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PAR PHARMACEUTICAL COMPANIES, INC. in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of PAR PHARMACEUTICAL COMPANIES, INC. since year 2005. Table 2 shows the detailed insider transactions of PAR PHARMACEUTICAL COMPANIES, INC. since 2005.
The reporting company's ticker symbol is PRX.
The reporting company's CIK number is 878088.
The total value of stock buying since 2005 is $7,240,209.
The total value of stock sales is $21,965,667.
The total value of stock exercises is $3,247,499.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at PAR PHARMACEUTICAL COMPANIES, INC. (PRX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at PAR PHARMACEUTICAL COMPANIES, INC. (PRX) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for PAR PHARMACEUTICAL COMPANIES, INC. (PRX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-03 | 20,000 | 345,888 | 0 | 0 | 0 | 0 |
| 2007-10 | 115,200 | 2,116,961 | 0 | 0 | 0 | 0 |
| 2007-02 | 0 | 0 | 465,000 | 12,510,499 | 0 | 0 |
| 2007-01 | 200 | 4,820 | 167,047 | 4,472,065 | 0 | 0 |
| 2006-07 | 330,600 | 4,615,341 | 0 | 0 | 0 | 0 |
| 2006-06 | 1,500 | 32,250 | 0 | 0 | 0 | 0 |
| 2006-01 | 0 | 0 | 155,535 | 4,983,103 | 150,000 | 3,247,499 |
| 2005-09 | 5,000 | 124,949 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for PAR PHARMACEUTICAL COMPANIES, INC. (PRX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-03-05 | Sharoky Melvin Md (Director) | Purchase | 20,000 | 17.29 | 345,888 |
| 2007-10-25 | Knight Peter S (Director) | Purchase | 2,500 | 18.10 | 45,237 |
| 2007-10-05 | Macphee John A (Exec VP, Pres Branded Prod Div) | Purchase | 3,000 | 18.70 | 56,100 |
| 2007-10-03 | Campanelli Paul (Exec VP, Pres-Generics Div) | Purchase | 2,100 | 18.19 | 38,199 |
| 2007-10-03 | Martino Gerard (EVP & Chief Operating Officer) | Purchase | 5,400 | 18.25 | 98,550 |
| 2007-10-03 | Haughey Thomas (Exec VP, General Counsel) | Purchase | 2,500 | 18.19 | 45,475 |
| 2007-10-03 | Smith Joseph E (Director) | Purchase | 50,000 | 18.45 | 922,540 |
| 2007-10-03 | Nordmann Ronald M (Director) | Purchase | 2,000 | 18.54 | 37,077 |
| 2007-10-03 | Lepore Patrick G (Chairman, CEO and President) | Purchase | 30,000 | 18.36 | 550,800 |
| 2007-10-03 | Abernathy John D (Director) | Purchase | 10,000 | 18.25 | 182,472 |
| 2007-02-01 | Deerfield Special Situations Fund International Lt (10% Owner) | Sale | 465,000 | 26.90 | 12,510,499 |
| 2007-01-31 | Deerfield Special Situations Fund International Lt (10% Owner) | Sale | 92,505 | 26.53 | 2,453,759 |
| 2007-01-30 | Deerfield Special Situations Fund International Lt (10% Owner) | Sale | 74,542 | 27.08 | 2,018,306 |
| 2007-01-25 | Cohen Steven A/sac Capital Mgmt Lp (10% Owner) | Purchase | 200 | 24.10 | 4,820 |
| 2006-07-18 | Deerfield International Ltd (Other) | Purchase | 330,600 | 13.96 | 4,615,341 |
| 2006-06-09 | Williams Peter (Director) | Purchase | 1,500 | 21.50 | 32,250 |
| 2006-01-31 | Gutman Arie (Other) | Sale | 5,535 | 32.74 | 181,188 |
| 2006-01-26 | Gutman Arie (Other) | Sale | 6,700 | 31.60 | 211,720 |
| 2006-01-26 | Gutman Arie (Other) | Option Exercise | 6,700 | 21.65 | 145,055 |
| 2006-01-25 | Gutman Arie (Other) | Sale | 60,000 | 31.83 | 1,909,800 |
| 2006-01-25 | Gutman Arie (Other) | Option Exercise | 60,000 | 21.65 | 1,299,000 |
| 2006-01-24 | Gutman Arie (Other) | Sale | 23,300 | 32.12 | 748,395 |
| 2006-01-24 | Gutman Arie (Other) | Option Exercise | 23,300 | 21.65 | 504,444 |
| 2006-01-23 | Gutman Arie (Other) | Sale | 60,000 | 32.20 | 1,932,000 |
| 2006-01-23 | Gutman Arie (Other) | Option Exercise | 60,000 | 21.65 | 1,299,000 |
| 2005-09-07 | Tarriff Scott L (CEO) | Purchase | 5,000 | 24.99 | 124,949 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of PAR PHARMACEUTICAL COMPANIES, INC. (symbol PRX,
CIK number 878088) see
the Securities and Exchange Commission (SEC) website.
|
|
